021-51111890
购物车（）
sales@molnova.cn
Velpatasvir
CAS No. 1377049-84-7
Velpatasvir ( GS-5816;GS 5816;GS5816 )
产品货号. M11558 CAS No. 1377049-84-7
Velpatasvir (GS-5816) is a second generation, pan-genotypic inhibitor of HCV NS5A, demonstrates a high barrier to resistance in HCV replicon assays.
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 10MG | ￥381 | 有现货 |
|
| 50MG | ￥851 | 有现货 |
|
| 100MG | ￥1320 | 有现货 |
|
| 200MG | ￥1968 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
生物学信息
-
产品名称Velpatasvir
-
注意事项本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断
-
产品简述Velpatasvir (GS-5816) is a second generation, pan-genotypic inhibitor of HCV NS5A, demonstrates a high barrier to resistance in HCV replicon assays.
-
产品描述Velpatasvir (GS-5816) is a second generation, pan-genotypic inhibitor of HCV NS5A, demonstrates a high barrier to resistance in HCV replicon assays.HCV Infection Phase 3 Clinical
-
同义词GS-5816;GS 5816;GS5816
-
通路Microbiology/Virology
-
靶点HCV
-
受体HCVNS5A
-
研究领域Infection
-
适应症HCV Infection
化学信息
-
CAS Number1377049-84-7
-
分子量883.00
-
分子式C49H54N8O8
-
纯度>98% (HPLC)
-
溶解度DMSO: 146.66 mg/mL (Need ultrasonic and warming)
-
SMILESO=C(OC)N[C@H](C1=CC=CC=C1)C(N2[C@H](C3=NC=C(C4=CC5=C(C6=CC7=CC=C8C(NC([C@H]9N(C([C@H](C(C)C)NC(OC)=O)=O)[C@@H](C)CC9)=N8)=C7C=C6OC5)C=C4)N3)C[C@H](COC)C2)=O
-
化学全称Carbamic acid, N-[(1R)-2-[(2S,4S)-2-[5-[1,11-dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4',3':6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinyl]-2-oxo-
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Curry MP, et al. N Engl J Med. 2015 Dec 31;373(27):2618-28.
2. Gane EJ, et al. Gastroenterology. 2016 Sep;151(3):448-456.e1.
3. Nakamoto S, et al. World J Gastroenterol. 2014 Mar 21;20(11):2902-12.
2. Gane EJ, et al. Gastroenterology. 2016 Sep;151(3):448-456.e1.
3. Nakamoto S, et al. World J Gastroenterol. 2014 Mar 21;20(11):2902-12.
产品手册
关联产品
-
NM107
A nucleoside inhibitor of HCV NS5B polymerase with EC50 of 1.23 uM against HCV 1b replicon cells.
-
Deleobuvir
Deleobuvir (BI-207127, BI207127) is a potent, selective HCV NS5B polymerase inhibitor with IC50 of 50 nM against GT-1 HCV polymerase activity.
-
Daclatasvir dihydroc...
A potent HCV NS5A inhibitor with EC50 of <50 pM against genotype 1 replicons.
